Reduced expression of FRG1 facilitates breast cancer progression via GM-CSF/MEK-ERK axis by abating FRG1 mediated transcriptional repression of GM-CSF
Abstract Multiple molecular subtypes and distinct clinical outcomes in breast cancer, necessitate specific therapy. Moreover, despite the improvements in breast cancer therapy, it remains the fifth cause of cancer-related deaths, indicating the involvement of unknown genes. To identify novel contrib...
Main Authors: | Bratati Mukherjee, Ankit Tiwari, Ananya Palo, Niharika Pattnaik, Subrat Samantara, Manjusha Dixit |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2022-11-01
|
Series: | Cell Death Discovery |
Online Access: | https://doi.org/10.1038/s41420-022-01240-w |
Similar Items
-
Role of FRG1 in predicting the overall survivability in cancers using multivariate based optimal model
by: Rehan Khan, et al.
Published: (2021-11-01) -
Reduced FRG1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasion
by: Ankit Tiwari, et al.
Published: (2019-04-01) -
Reduced FRG1 expression promotes angiogenesis via activation of the FGF2‐mediated ERK/AKT pathway
by: Bratati Mukherjee, et al.
Published: (2023-05-01) -
Unveiling FRG1’s DNA repair role in breast cancer
by: Shubhanjali Shubhanjali, et al.
Published: (2024-08-01) -
Recombinant GM-CSF for diseases of GM-CSF insufficiency: Correcting dysfunctional mononuclear phagocyte disorders
by: Hillard M. Lazarus, et al.
Published: (2023-01-01)